EcoR1 Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-887,076	Closed	-$19.1M	–	63
2023 Q4	$19.1M	Buy	887,076 +687,080	+344%	+$14.8M	0.5%	32
2023 Q3	$2.45M	Sell	199,996 -4	-0%	-$49	0.08%	43
2023 Q2	$2.25M	Buy	+200,000	New	+$2.25M	0.06%	43